Example: Heart Attack

Search clinical trials for: machine-learning algorithm

Total 10000 results

NCT07042126

Recruiting

Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic
NCT06751940

Recruiting

Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment

Colorectal Cancer (CRC)
NCT06788600

Not yet recruiting

Mechanistic Study of EBV mRNA Vaccine (WGc-043) in EBV-Positive Relapsed/Refractory Lymphoma (WGc-043)

Epstein-Barr Virus Associated Lymphoma
NCT05930730

Recruiting

Immunogenicity and Safety of Comvigen (Bivalent) Vaccine

Safety of a Single Dose of COMVIGEN Vaccine | Reactogenicity of a Single Dose of COMVIGEN Vaccine | Immunogenicity of a Single Dose of COMVIGEN Vaccine | Safety of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Reactogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine | Immunogenicity of a Single Dose of BIVALENT Pfizer/BNT Vaccine
NCT05019248

Recruiting

Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine (CIRMS)

Multiple Sclerosis, Relapsing-Remitting | Vaccine Response Impaired
NCT05003466

Not yet recruiting

Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19)

COVID-19
NCT07583160

Enrolling by invitation

YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer (YS247)

Prostate Neoplasms | Castration-Resistant Prostate Cancer (CRPC) | Metastatic Castration-Resistant Prostate Cancer Patients
NCT03209713

Active, not recruiting

Edtech-HPV: A Community Approach Using Education and Technology to Increase HPV Vaccination (Edtech-HPV)

Parents
NCT02325310

Completed

Search for the Measles Vaccine Virus Excretion in Breast Milk of Breastfeeding Women After Postpartum Vaccination With MMR (BREMEAVAC)

Measles | Rubella | Mumps
NCT03059485

Active, not recruiting

DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission

Acute Myelogenous Leukemia
NCT05236595

Enrolling by invitation

Research for Individualized Therapeutics in Rare Genetic Disease

Undiagnosed Diseases | Rare Genetic Disease
NCT05740813

Completed

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Amyotrophic Lateral Sclerosis
NCT05526716

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)

Pneumonia, Pneumococcal
NCT04083430

Active, not recruiting

Cytotoxicity of Yellow Fever Specific CD8 T Cells Following YF-17D Vaccination (CYF-8)

Healthy | Cytotoxicity | Yellow Fever Vaccination Reaction
NCT06454175

Active, not recruiting

A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years

HPV Infection | HPV-Related Carcinoma | Genital Wart | HPV-Related Intraepithelial Neoplasia
NCT01588015

Completed

Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma
NCT04691908

Completed

Immunogenicity, Efficacy and Safety of QazCovid-in® COVID-19 Vaccine

Covid19 | Vaccine Adverse Reaction | SARS-CoV Infection
NCT05939596

Active, not recruiting

A Phase I Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021)

SARS-CoV-2
NCT02740777

Completed

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Cervical Intraepithelial Neoplasia | Human Papillomavirus | Persistent Infection
NCT05323461

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
NCT02733068

Completed

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Cervical Intraepithelial Neoplasia | Human Papilloma Virus Infection Type 16 | Human Papilloma Virus Infection Type 18
NCT04671472

Completed

Efficacy Confirmation Study of NPC-09

GNE Myopathy | Nonaka Disease | Distal Myopathy With Rimmed Vacuoles (DMRV) | Hereditary Inclusion Body Myopathy (hIBM)
NCT04830371

Completed

Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants

Typhoid Fever
NCT04313127

Completed

Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults (CTCOVID-19)

COVID-19
NCT04071158

Completed

A STUDY OF A RSV VACCINE WHEN GIVEN TOGETHER WITH TDAP IN HEALTHY NONPREGNANT WOMEN AGED BETWEEN 18 TO 49 YEARS

Respiratory Tract Infection
NCT04648800

Unknown

Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland

Covid19 | SARS-CoV Infection | BCG Vaccination Reaction
NCT03055195

Terminated

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

Dermatitis, Atopic
NCT01094496

Terminated

A Study of the CDX-1307 Vaccine Regimen in Patients With Newly Diagnosed Muscle-Invasive Bladder Cancer (The "N-ABLE" Study)

Bladder Cancer
NCT02709993

Withdrawn

Consolidation Therapy in Patients With Hematologic Malignancies

Cancer | Hematologic Malignancies
NCT01340898

Completed

Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers

Meningococcal Infection
NCT00508261

Completed

Co-Administration of Meningococcal Vaccine GSK134612 With Infanrix Hexa™ Versus Individual Administration of Each Vaccine

Infections, Meningococcal
NCT00453986

Completed

Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Infections, Meningococcal
NCT02705703

Withdrawn

Consolidation Therapy in Patients With Metastatic Solid Malignancies

Cancer | Metastatic Solid Malignancies
NCT02937233

Completed

Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study (Z001)

Zika
NCT00742885

Completed

Immunogenicity and Safety of GSK Biologicals' (Pre-) Pandemic Influenza Candidate Vaccine

Influenza
NCT00765076

Completed

Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

Influenza
NCT02724254

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Topical Applications of AP611074 5% Gel for up to 16 Weeks in Condyloma Patients

Condyloma
NCT01896830

Completed

Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in Japan

Clostridium Difficile Infection
NCT01961115

Completed

Epacadostat and Vaccine Therapy in Treating Patients With Stage III-IV Melanoma

Stage IV Skin Melanoma | Recurrent Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Mucosal Melanoma | Stage IV Uveal Melanoma | Stage IIIA Skin Melanoma | Stage IIIA Uveal Melanoma | Stage IIIB Uveal Melanoma | Stage IIIC Uveal Melanoma
NCT00321373

Completed

Study to Evaluate an Influenza Vaccine Candidate

Influenza
NCT01923116

Completed

Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia (VACCAIN-T)

HIV | Anal Intraepithelial Neoplasia
NCT01873040

Completed

Vaccine Social Media Randomized Intervention Trial (VSMRCT)

Communicable Diseases
NCT01013974

Completed

A Study of GSK573719 in Healthy Japanese Male Subjects

Pulmonary Disease, Chronic Obstructive
NCT03237663

Completed

Safety of An Oral O1 / O139 Cholera Vaccine (Enteric Capsules)

Safety of the Oral O1 / O139 Cholera Vaccine (Enteric Capsules)
NCT02713620

Completed

Hepatitis B Vaccination in HIV-infected Adults

Hepatitis B
NCT01654263

Completed

A Phase IIb, Open-Label, Dose Ranging Study of 13-Valent Pneumococcal Conjugate Vaccine in Adults 55 Through 74 Years of Age Previously Vaccinated With 23-Valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infection
NCT02115126

Withdrawn

Phase II Trial to Evaluate an EBV-derived Dendritic Cell Vaccine in Autologous Stem Cell Transplant

Hodgkin Lymphoma | Non-Hodgkin Lymphoma
NCT02417597

Completed

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)

Hepatitis E
NCT00258908

Completed

Immunogenicity and Safety of ADACEL™ as Fifth Dose in Taiwan

Pertussis | Tetanus | Diphtheria
NCT02693236

Unknown

DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer

Esophagus Cancer

Search clinical trials for: machine-learning algorithm

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations